Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction.

Hochholzer W, Reichlin T, Stelzig C, Hochholzer K, Meissner J, Breidthardt T, Reiter M, Duehsler B, Freidank H, Winkler K, Twerenbold R, Mueller C.

Eur Heart J. 2011 Feb;32(3):326-35. doi: 10.1093/eurheartj/ehq429. Epub 2010 Dec 7.

2.

Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.

Kodama Y, Kitta Y, Nakamura T, Takano H, Umetani K, Fujioka D, Saito Y, Kawabata K, Obata JE, Mende A, Kobayashi T, Kugiyama K.

J Am Coll Cardiol. 2006 Jul 4;48(1):43-50. Epub 2006 Jun 9.

3.

N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.

Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.

Am J Med. 2011 Aug;124(8):731-9. doi: 10.1016/j.amjmed.2011.02.035.

PMID:
21787902
4.

Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction.

Potocki M, Reichlin T, Thalmann S, Zellweger C, Twerenbold R, Reiter M, Steuer S, Bassetti S, Drexler B, Stelzig C, Freese M, Winkler K, Haaf P, Balmelli C, Hochholzer W, Osswald S, Mueller C.

Heart. 2012 Apr;98(7):558-65. doi: 10.1136/heartjnl-2011-301269. Epub 2012 Feb 15.

PMID:
22337952
5.

An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.

Matsumoto T, Uemura S, Takeda Y, Matsui M, Okada S, Nishida T, Soeda T, Okayama S, Somekawa S, Ishigami K, Onoue K, Kawata H, Kawakami R, Horii M, Saito Y.

Intern Med. 2013;52(10):1019-27. Epub 2013 May 15.

6.

Utility of C-terminal proendothelin in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction.

Haaf P, Zellweger C, Reichlin T, Zbinden A, Wildi K, Mosimann T, Twerenbold R, Reiter M, Balmelli C, Freidank H, Gimenez MR, Peter F, Freese M, Stelzig C, Hartmann B, Dinter C, Osswald S, Mueller C.

Can J Cardiol. 2014 Feb;30(2):195-203. doi: 10.1016/j.cjca.2013.11.020. Epub 2013 Nov 23.

PMID:
24461921
7.

No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.

Poldervaart JM, Röttger E, Dekker MS, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, van 't Hof AW, Mosterd A, Hoes AW.

PLoS One. 2015 Jul 15;10(7):e0132000. doi: 10.1371/journal.pone.0132000. eCollection 2015.

8.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
9.

Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery.

Weber M, Luchner A, Seeberger M, Mueller C, Liebetrau C, Schlitt A, Apostolovic S, Jankovic R, Bankovic D, Jovic M, Mitrovic V, Nef H, Mollmann H, Hamm CW.

Eur Heart J. 2013 Mar;34(11):853-62. doi: 10.1093/eurheartj/ehs445. Epub 2012 Dec 19. Erratum in: Eur Heart J. 2013 Jun;34(24):1853. Manfred, Seeberger [corrected to Seeberger, Manfred].

10.

Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.

Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P, Reichlin T, Irfan A, Reiter M, Zellweger C, Meissner J, Stelzig C, Freese M, Capodarve I, Mueller C.

Am J Cardiol. 2012 Apr 15;109(8):1117-23. doi: 10.1016/j.amjcard.2011.11.047. Epub 2012 Jan 17.

PMID:
22257708
11.

Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia.

Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Gómez-Montes E, Denk B, Galindo A.

Ultrasound Obstet Gynecol. 2013 May;41(5):530-7. doi: 10.1002/uog.12400. Epub 2013 Apr 11.

12.

Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.

Rambod M, Heine GH, Seiler S, Dominic EA, Rogacev KS, Dwivedi R, Ramezani A, Wing MR, Amdur RL, Fliser D, Raj DS.

Atherosclerosis. 2014 Oct;236(2):360-5. doi: 10.1016/j.atherosclerosis.2014.07.026. Epub 2014 Aug 12.

13.

The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Ky B, French B, Ruparel K, Sweitzer NK, Fang JC, Levy WC, Sawyer DB, Cappola TP.

J Am Coll Cardiol. 2011 Jul 19;58(4):386-94. doi: 10.1016/j.jacc.2011.03.032.

14.

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.

Eur Heart J. 2009 May;30(9):1057-65. doi: 10.1093/eurheartj/ehn600. Epub 2009 Jan 23.

15.

Prognostic value of placental growth factor in patients with acute chest pain.

Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simoons ML, Zeiher AM; CAPTURE Investigators.

JAMA. 2004 Jan 28;291(4):435-41.

PMID:
14747500
16.

Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction.

Liebetrau C, Nef HM, Dörr O, Gaede L, Hoffmann J, Hahnel A, Rolf A, Troidl C, Lackner KJ, Keller T, Hamm CW, Möllmann H.

Heart. 2014 Apr;100(8):652-7. doi: 10.1136/heartjnl-2013-305253. Epub 2014 Jan 31.

PMID:
24488609
17.

Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.

Rohra DK, Zeb A, Qureishi RN, Azam SI, Khan NB, Zuberi HS, Sikandar R.

Natl Med J India. 2012 Mar-Apr;25(2):68-73.

PMID:
22686711
18.

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.

Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdés M, Januzzi JL.

Eur J Heart Fail. 2011 Jul;13(7):718-25. doi: 10.1093/eurjhf/hfr047. Epub 2011 May 6.

19.

Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department.

Aldous SJ, Florkowski CM, Crozier IG, Elliott J, George P, Lainchbury JG, Mackay RJ, Than M, Flaws DF, Borowsky J.

Ann Clin Biochem. 2011 May;48(Pt 3):241-8. doi: 10.1258/acb.2010.010219. Epub 2011 Mar 25. Erratum in: Ann Clin Biochem. 2012 Mar;49(Pt 2):208. Flaws, Dylan Finlay [added]; Borowsky, Jennifer [added].

PMID:
21441390
20.

High-sensitivity versus conventional troponin in the emergency department for the diagnosis of acute myocardial infarction.

Freund Y, Chenevier-Gobeaux C, Bonnet P, Claessens YE, Allo JC, Doumenc B, Leumani F, Cosson C, Riou B, Ray P.

Crit Care. 2011 Jun 10;15(3):R147. doi: 10.1186/cc10270.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk